Today: 23 May 2026
Browse Category

NASDAQ:MDIN 22 May 2026

Medline’s $2.7 billion stock sale puts demand for IPO favorite on the line

Medline’s $2.7 billion stock sale puts demand for IPO favorite on the line

Medline shareholders priced a 72.6 million-share secondary offering at $37 each, raising $2.68 billion, with the company receiving no proceeds. Shares traded near $37 late Friday, above the $29 IPO price but below December’s peak. The offering was upsized from 60 million shares, with underwriters holding an option for more. Major sellers include affiliates of Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority.
22 May 2026
·

Stock Market Today

  • Opinion: What Investors Should Understand About AI IPOs
    May 22, 2026, 7:31 PM EDT. AI initial public offerings (IPOs) differ significantly from the internet stock boom, driven by unique factors including heightened national security concerns. Investors should recognize that the dominant influence in AI markets may be government agencies prioritizing security, not just pure commercial interests. This shapes the growth trajectory and regulatory landscape of AI companies going public.

Latest articles

Baiya Stock Doubles After $1 Million BNB Bet: What Just Happened to BIYA

Baiya Stock Doubles After $1 Million BNB Bet: What Just Happened to BIYA

23 May 2026
Baiya International Group shares surged 110.5% to $1.30 Friday after the company said it invested $1 million in Binance Coin (BNB) and launched a “Binance Plan” following a public vote. Trading volume hit 101.17 million shares, far above average. Baiya also activated four algorithmic trading strategies linked to BNB, with possible share buybacks. The company’s core business remains recruitment in China, with a 2025 net loss of $9.5 million.
Femasys Jumps Almost 30% as Nasdaq Deadline Remains

Femasys Jumps Almost 30% as Nasdaq Deadline Remains

23 May 2026
Femasys shares closed up 29.9% at 43.8 cents on Friday, with volume surging to nearly 15 million shares, far above average. The rally left the stock below Nasdaq’s $1 minimum bid requirement. No new company filings or news were released in the past 48 hours. Femasys last reported CE Mark approval for its FemHSG catheter and first-quarter sales of $424,889.
Micron slips in New York; memory push keeps focus on AI signal

Micron slips in New York; memory push keeps focus on AI signal

23 May 2026
Micron shares fell 1.46% to $751.00 Friday after the company began 1-alpha DRAM production at its Manassas, Virginia, plant. The move came amid a volatile week for memory-chip stocks, with Samsung labor news and AI demand influencing trading. U.S. Trade Representative Jamieson Greer said no immediate semiconductor tariffs are planned. U.S. markets will close Monday for Memorial Day.
Go toTop